The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation
Open accessAbstract
Diabetic cardiomyopathy is characterized by impaired cardiac contractility leading to poor myocardial performance. We investigated the role that the hexosamine pathway, and especially altered nuclear O-Glc-NAcylation, plays in the development of diabetic cardiomyopathy. Incubating neonatal rat cardiomyocytes in high glucose (25 mM) resulted in prolonged calcium transients when compared with myocytes incubated in normal glucose (5.5 mM), which is consistent with delayed myocardial relaxation. High glucose-treated myocytes also exhibited reduced sarcoendoplasmic reticulum Ca(2+)-ATPase 2a (SERCA2a) mRNA and protein expression, decreased SERCA2a promoter activity, and increased O-GlcNAcylation of nuclear proteins compared with myocytes treated with normal glucose. Exposure of myocytes to 8 mM glucosamine or an adenovirus expressing O-GlcNAc-transferase (OGT) resulted in prolonged calcium transient decays and significantly reduced SERCA2a protein levels, whereas treatment with an adenovirus encoding O-GlcNAcase (GCA) resulted in improved calcium transients and SERCA2a protein levels in myocytes exposed to high glucose. Effects of elevated glucose or altered O-GlcNAcylation were also observed on essential transcription factors involved in cardiomyocyte function. High glucose-treated myocytes (with or without OGT adenovirus) exhibited increased levels of O-GlcNAcylated specificity protein 1 compared with control myocytes, whereas infecting high glucose-treated myocytes with GCA adenovirus reduced the degree of specificity protein 1 Glc-NAcylation. Treatment of myocytes with 25 mM glucose, 8 mM glucosamine, or OGT adenovirus also significantly reduced levels of myocytes enhancer factor-2A protein compared with control myocytes, whereas infection with GCA adenovirus resulted in improved myocytes enhancer factor-2 expression. Our results suggest that the hexosamine pathway, and O-GlcNAcylation in particular, is important in impaired cardiac myocyte function and the development of diabetic cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
INTRACELLULAR CALCIUM HOMEOSTASIS
Carafoli, E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002143 · Cited by 2,190
Marshall, S., Bacote, V, & Traxinger, R. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67706-9 · Cited by 1,047
TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINS
Black, B. L., & Olson, E. N. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.167 · Cited by 1,039
Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc
Wells, L., Vosseller, K., & Hart, G. W. (2001) · Science · doi:10.1126/science.1058714 · Cited by 954
Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins
Gao, Y., Wells, L., Comer, F. I., Parker, G. J., & Hart, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010420200 · Cited by 761
Galderisi, M., Anderson, K. M., Wilson, P. W. F., & Levy, D. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90716-x · Cited by 552
DYNAMIC O-LINKED GLYCOSYLATION OF NUCLEAR AND CYTOSKELETAL PROTEINS
Hart, G. W. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.315 · Cited by 508
Cited by
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Glycosylation in health and disease
Reily, C., Stewart, T. J., Renfrow, M. B., & Novak, J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0129-4 · Cited by 2,075
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins
Hart, G. W., Housley, M. P., & Slawson, C. (2007) · Nature · doi:10.1038/nature05815 · Cited by 1,418
Hart, G. W., Slawson, C., Ramirez-Correa, G., & Lagerlof, O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060608-102511 · Cited by 1,317
“Hyperglycemic-induced increased O-GlcNAcylation results in prolonged calcium transient decays in cardiomyocytes and decreases the expression of the critical sarcoplasmic calcium ATPase, SERCA2a, which may be mediated by the hyper-O-GlcNAcylation of the Sp1 transcription factor (214).”
BackgroundCardiac Metabolism in Heart Failure: Implications Beyond ATP Production
Doenst, T., Nguyen, T. D., & Abel, E. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300376 · Cited by 1,111
(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Shah, M. S., & Brownlee, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306923 · Cited by 602
Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 571
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Hexosamines, insulin resistance, and the complications of diabetes: current status
Buse, M. G. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2005 · Cited by 512
Endoplasmic-Reticulum Calcium Depletion and Disease
Mekahli, D., Bultynck, G., Parys, J. B., De Smedt, H., & Missiaen, L. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004317 · Cited by 478
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus
Katakami, N. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17014 · Cited by 472
Diabetic cardiomyopathy: pathophysiology and clinical features
Miki, T., Yuda, S., Kouzu, H., & Miura, T. (2013) · Heart Failure Reviews · doi:10.1007/s10741-012-9313-3 · Cited by 460
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
An, D., & Rodrigues, B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00278.2006 · Cited by 446
ZACHARA, N. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.03.016 · Cited by 426
Butkinaree, C., Park, K., & Hart, G. W. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.018 · Cited by 415
Return to the fetal gene program: A suggested metabolic link to gene expression in the heart
Taegtmeyer, H., Sen, S., & Vela, D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05100.x · Cited by 411
Cell signaling, the essential role of O-GlcNAc
Zachara, N. E., & Hart, G. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.04.007 · Cited by 386
Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology
Chatham, J. C., Zhang, J., & Wende, A. R. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2019 · Cited by 352
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
Slawson, C., Copeland, R. J., & Hart, G. W. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.005 · Cited by 346
Nutrient regulation of signaling and transcription
Hart, G. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aw119.003226 · Cited by 345
The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine
Hanover, J. A., Krause, M. W., & Love, D. C. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.017 · Cited by 342
O-GlcNAc Regulates FoxO Activation in Response to Glucose
Housley, M. P., Rodgers, J. T., Udeshi, N. D., Kelly, T. J., Shabanowitz, J., Hunt, D. F., Puigserver, P., & Hart, G. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802240200 · Cited by 336
Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
Tran, D. H., & Wang, Z. V. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012673 · Cited by 335
O-GlcNAc Cycling: A Link Between Metabolism and Chronic Disease
Bond, M. R., & Hanover, J. A. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161240 · Cited by 316
Glucose metabolism and cardiac hypertrophy
Kolwicz, S. C., & Tian, R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr071 · Cited by 304
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 292
Slawson, C., Zachara, N. E., Vosseller, K., Cheung, W. D., Lane, M. D., & Hart, G. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503396200 · Cited by 291
Hu, Y., Suarez, J., Fricovsky, E., Wang, H., Scott, B. T., Trauger, S. A., Han, W., Hu, Y., Oyeleye, M. O., & Dillmann, W. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808518200 · Cited by 253
Self-citationProtein O-GlcNAcylation in diabetes and diabetic complications
Ma, J., & Hart, G. W. (2013) · Expert Review of Proteomics · doi:10.1586/14789450.2013.820536 · Cited by 252
A Drosophila Model of High Sugar Diet-Induced Cardiomyopathy
Na, J., Musselman, L. P., Pendse, J., Baranski, T. J., Bodmer, R., Ocorr, K., & Cagan, R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003175 · Cited by 252
Decreased Sarcoplasmic Reticulum Activity and Contractility in Diabetic db/db Mouse Heart
Belke, D. D., Swanson, E. A., & Dillmann, W. H. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3201 · Cited by 252
Self-citationNuttall, F. Q., Ngo, A., & Gannon, M. C. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.863 · Cited by 146
Younce, C. W., Burmeister, M. A., & Ayala, J. E. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00248.2012 · Cited by 134
Li, S.-Y., Sigmon, V. K., Babcock, S. A., & Ren, J. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.11.035 · Cited by 97
Li, S. ‐., Liu, Y., Sigmon, V. K., McCort, A., & Ren, J. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00387.x · Cited by 95
Joubert, M., Manrique, A., Cariou, B., & Prieur, X. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.07.003 · Cited by 81
Suarez, J., Hu, Y., Makino, A., Fricovsky, E., Wang, H., & Dillmann, W. H. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00076.2008 · Cited by 77
Self-citationLeichman, J. G., Aguilar, D., King, T. M., Vlada, A., Reyes, M., & Taegtmeyer, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.336 · Cited by 64
Metadata
- Authors
- Clark, R. J., McDonough, P. M., Swanson, E., Trost, S. U., Suzuki, M., Fukuda, M., & Dillmann, W. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 278
- Issue
- 45
- Pages
- 44230-44237
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2074332237
- Cited by
- 382
- References
- 40
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.